Role of quercetin and arginine in ameliorating nano zinc oxide-induced nephrotoxicity in rats

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Faddah, Laila M ^a   Baky, Nayira A A ^a   Al Rasheed, Nouf M ^a   Al Rasheed, Nawal M ^a   Fatani, Amal J ^a   Atteya, Muhammad ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Arg; C reactive protein (CRP); Interleukin 6 (IL 6); Nano Zinc oxide; Qur; Tumor necrosis factor alpha (TNF ); Vascular endothelium growth factor (VEGF)

Indexed keywords

ARGININE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN G; INTERLEUKIN 6; NANOPARTICLE; NITRIC OXIDE; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA; UREA; VASCULOTROPIN; ZINC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULITIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY PARENCHYMA; NEPHROTOXICITY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; UREA BLOOD LEVEL;

EID: 84860342696     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-60     Document Type: Article

References (68)

1. Van Tassel K A and Goldman R The Growing consumer exposure to nanotechnology in everyday product: Regulating innovative technologies in light of lessons from the past. Connecticut Law Review, Vol. 44, No. 2, 2011, Van Tassel K A and Goldman R.
2. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence and lung injury. Environ Health Perspect 1994, 102(5):173-179. 10.1289/ehp.94102s5173, 1566999, 7705294.
3. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005 Oct, 2:8.
4. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839. 10.1289/ehp.7339, 1257642, 16002369.
5. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005 Oct, 2:10.
6. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003, 21(10):1166-1170. 10.1038/nbt875, 14520401.
7. Møller P, Jacobsen NR, Folkmann JK, Danielsen PH, Mikkelsen L, Hemmingsen JG, Vesterdal LK, Forchhammer L, Wallin H, Loft S. Role of oxidative damage in toxicity of particulates. Free Radic Res 2010, 44(1):1-46. 10.3109/10715760903300691, 19886744.
8. Li N, Sioutas C, Cho A, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochrondrial damage. Environ Health Perspect 2003, 111:455-460. 1241427, 12676598.
9. Koeneman BA, Zhang Y, Westerhoff P, Chen Y, Crittenden JC. C DG: Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol 2010, 26(3):225-238. 10.1007/s10565-009-9132-z, 19618281.
10. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002, 105(4):411-414. 10.1161/hc0402.104118, 11815420.
11. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. Areview of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010, 40(4):328-346. 10.3109/10408440903453074, 20128631.
12. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004, 16:453-459. 10.1080/08958370490439650, 15204761.
13. Kim HJ, Yu BP, Chung HY. Molecular exploration of age-related NF-kappaB/IKK downregulation by calorie restriction in rat kidney. Free Radic Biol Med 2002, 32:991-1005. 10.1016/S0891-5849(02)00798-0, 12008115.
14. Sanhueza J, Valdes J, Campos R, Garrido A, Valenzuela A. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids. Res Commun Chem Pathol Pharmacol 1992 Nov, 78(2):211-218.
15. Wang H, Joseph JA. Structure-activity relationships of Quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Radic Biol Med 1999 Sep, 27(5-6):683-694.
16. Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen 2003, 11(6):419-423. 10.1046/j.1524-475X.2003.11605.x, 14617280.
17. Wu G, Jaeger LA, Bazer FW, Rhoads JM. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 2004 Aug, 15(8):442-451.
18. Stechmiller JK, Childress B, Cowan L. Arginine supplementation and wound healing. Nutr Clin Pract 2005, 20:52-61. 10.1177/011542650502000152, 16207646.
19. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999 Aug, 43(3):521-531.
20. Isenberg JS, Ridnour LA, Espey MG, Wink DA, Roberts DD. Nitric oxide in wound-healing. Microsurgery 2005, 25(5):442-451. 10.1002/micr.20168, 16044466.
21. Gokce N. Arginineinine and hypertension. J Nutr 2004, 134(10 Suppl):2807-2811.
22. Reyes AA, Karl IE, Klahr S. Role of Arginineinine in health and in renal disease. AJP-Renal Physiol 1994, 267:f331-f346.
23. Higashi Y, Oshima T, Ozono R, Watanabe M, Matsuura H, Kajiyama G. Effects of Arginineinineinine Infusion on Renal Hemodynamics in Patients With Mild Essential Hypertension. Hypertension 1995, 25:898-902. 10.1161/01.HYP.25.4.898, 7721451.
24. Wang B, Feng WY, Wang TC, Jia G, Wang M, Shi JW, Zhang F, Zhao YL, Chai ZF. Acute toxicological impact of nano-and submicro-scaled zinc oxide powder on healthy adult mice. Toxicol Lett 2006 Feb, 161(2):115-123.
25. Kambe D, Kotani M, Yoshimoto M, Kaku S, Chaki S, Honda K. Effects of Quercetin on the sleep-wake cycle in rats: involvement of gamma-aminobutyric acid receptor type A in regulation of rapid eye movement sleep. Brain Res 2010 May, 1330:83-88.
26. El-Missiry MA, Othman AI, Amer MA. Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol 2004, 24(2):93-97. 10.1002/jat.952, 15052603.
27. Kim N, Kim YJ, Cho DK. Gold nanoparticle-based signal augmentation of quartz crystal microbalance immunosensor measuring C-reactive protein. Curr Appl Phys 2010, 10(4):1227-1230.
28. Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005 May, 4(2):220-226.
29. Kaden J. IL-6 determination in serum of kidney graft recipients by a new bedside test: its diagnostic relevance. Transplant Proc 2007 Mar, 39(2):511-513.
30. Moshage H, Kok B, Uuizenga JR, Jansen P. Nitrite and Nitrate Determination in Plasma: A Critical Evaluation. Clin Chim 1995, 41:892-896.
31. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969, 6:24-25.
32. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979 Jan, 582(1):67-78.
33. Smith A, Bruton J. A colour Atlas of histological staining techniques. J Clin Pathol 1978, 31(3):298.
34. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 2008, 5(2):316-327. 10.1021/mp7001285, 18217714.
35. Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, Larson SM, Wiesner U, Bradbury M. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 2009, 9(1):442-448. 10.1021/nl803405h, 19099455.
36. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S, Bentolila LA, Li J, Rao J, Chen X, Banin U, Wu AM, Sinclair R, Weiss S, Gambhir SS. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5(1):126-134. 10.1002/smll.200800003, 3084659, 19051182.
37. BeruBe K, Balharry D, Sexton K, Koshy L, Jones T. Combustion-derived nanoparticles: mechanisms of pulmonary toxicity. Clin Exp Pharmacolm Physiol 2007, 34(10):1044-1050.
38. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, Zhu C, Fang X, Ma B, Wan L. Acute toxicological effects of copper of engineered nanomaterials. Nat Nanotechnol 2007, 2:469-478. 10.1038/nnano.2007.223, 18654343.
39. Tsou TC, Yeh SC, Tsai FY, Lin HJ, Cheng TJ, Chao HR, Tai LA. Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. J Hazard Mater 2010 Nov, 183(1-3):182-188.
40. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Beckett WS. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. J Occup Environ Med 1997 Aug, 39(8):722-726.
41. Ivanov V, Cha J, Ivanova S, Kalinovsky T, Roomi MW, Rath M, Niedzwiecki A. Essential nutrients suppress inflammation by modulating key inflammatory gene expression. Int J Mol Med 2008, 22:731-741.
42. Mostafavi-Pour Z, Zal F, Monabati A, Vessal M. Protective effects of a combination of Quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatol Res 2008 Apr, 38(4):385-392.
43. Behling EB, Sendão MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L. Comparative study of multiple dosage of Quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep 2006, 58(4):526-532.
44. Karlsen A, Paur I, Bøhn SK, Sakhi AK, Borge GI, Serafini M, Erlund I, Laake P, Tonstad S, Blomhoff R. Bilberry juice modulates plasma concentration of NF-kappa B related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 2010 Sep, 49(6):345-355.
45. Ying B, Yang T, Song X, Hu X, Fan H, Lu X, Chen L, Cheng D, Wang T, Liu D, Xu D, Wei Y, Wen F. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol Biol Rep 2009 Sep, 36(7):1825-1832.
46. Yu ES, Min HJ, An SY, Won HY, Hong JH, Hwang ES. Regulatory mechanisms of IL-2 and IFNgamma suppression by Quercetin in T helper cells. Biochem Pharmacol 2008 Jul, 76(1):70-78.
47. Liu MY, Cheng YJ, Chen CK, Yang BC. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 2005 Apr, 23(4):360-364.
48. Hushmendy S, Jayakumar L, Hahn AB, Bhoiwala D, Bhoiwala DL, Crawford DR. Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation. Nutr Res 2009 Aug, 29(8):568-578.
49. Huang CC, Tsai SC, Lin WT. Potential ergogenic effects of Arginineinine against oxidative and inflammatory stress induced by acute exercise in aging rats. Exp Gerontol 2008 Jun, 43(6):571-577.
50. Wu GH, Zhang YW, Wu ZH. Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World J Gastroenterol 2001 Jun, 7(3):357-362.
51. Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of Quercetin in human in vitro and in vivo models. Atherosclerosis 2011, 218(1):44-52. 10.1016/j.atherosclerosis.2011.04.023, 21601209.
52. Pujalté I, Passagne I, Brouillaud B, Tréguer M, Durand E, Ohayon-Courtès C, L'Azou B. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol 2011 Mar, 8:10.
53. Pfeilschifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R. Interleukin 1β and tumour necrosis factor α induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 1992 Jan, 203(1-2):251-255.
54. Saura M, López S, Rodríguez Puyol M, Rodríguez Puyol D, Lamas S. Regulation of inducible nitric oxide synthase expression in rat mesangial cells and isolated glomeruli. Kidney Int 1995, 47(2):500-509. 10.1038/ki.1995.63, 7536858.
55. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 1993 May, 91(5):2138-2143.
56. Cook HT, Ebrahim H, Jansen AS, Foster GR, LArginineen P, Cattell V. Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat. Clin Exp Immun 2008, 97(2):315-320.
57. Ding YH, Luan XD, Li J, Rafols JA, Guthinkonda M, Diaz FG, Ding Y. Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Curr Neurovasc Res 2004 Dec, 1(5):411-420.
58. Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, De Martin R, Binder BR, Hofer E. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J 2001 Jan, 15(1):230-242.
59. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Invest Dermaol Symp Proc 2000, 5:40-46.
60. Verheul HM, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000, 96:4216-4221.
61. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001, 125:67-71.
62. Sano H, Hosokawa K, Kidoya H, Takakura N. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Arterioscler Thromb Vasc Biol 2006 Dec, 26(12):2673-2680.
63. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997 May, 11(6):457-465.
64. Honkanen EO, Teppo AM, Grönhagen-Riska C. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int 2000 Jun, 57(6):2343-2349.
65. Heffernan D, Dudley B, McNeil PL, Howdieshell TR. Local Arginine supplementation results in sustained wound nitric oxide production and reductions in vascular endothelial growth factor expression and granulation tissue formation. J Surg Res 2006 Jun, 133(1):46-54.
66. Fukahori M, Ichimori K, Ishida H, Nakagawa H, Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radic Res 1994, 21:203-212. 10.3109/10715769409056572, 7827692.
67. Satyanarayana PS, Singh D, Chopra K. Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Meth Find Exp Clin Pharmacol 2001 May, 23(4):175-181.
68. Lin W, Yang S, Tsai S, Huang C, Lee N. Arginineinine attenuates xanthine oxidase and myeloperoxidase activities in hearts of rats during exhaustive exercise. Br J Nutr 2006, 95:67-75. 10.1079/BJN20051602, 16441918.